Rick Williamson Email & Phone Number

Bethlehem, Pa, Us

Executive Leader in Marketing, Sales, and Sustainability. Demonstrated track record for maximizing short-term earnings while creating and maintaining focus on long-term, strategic vision. Expertise in Diagnostic Imaging, Pharmaceutical, and Medical Device Industries with with direct responsibility for the development of Sustainability initiatives directly related to patient health. in-depth brand launch and market development expertise in Cardiology, Oncology, Anti-thrombosis, Antibiotics, Women’s Health and Children’s Health initiatives. resulting in substantial growth of multiple brands and outstanding franchise performance, globally.

Bethlehem, Pa, Us

In the Channel Marketing position, responsibilities include leading the Channel Marketing Team in the development of marketing, service and educational programs, utilizing all products and resources across BBMUS group of businesses, focused on specific customer segments including Integrated Delivery Networks (IDN), Group Purchasing Organizations (GPO), Distribution, Government, and specific Out Patient Markets (OPM) including Surgery Centers, Oncology Centers and Home Infusion Therapy. In addition, his team is focused on the development and execution of process optimization programs that support customer initiatives in achieving their Triple/Quadruple Aim objectives: Improve patient experience, Improve overall population health of Americans, Decrease the per capita cost of health care, and Improve the experience of providing care.Rick leads a corporate initiative focused on environmental health and patient safety with a primary focus on the elimination of Endocrine Disrupting Compounds (EDC), such as phthalates, out of healthcare products.

Bethlehem, Pa, Us

B. Braun Medical Inc. (B.Braun) is a global leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its “Sharing Expertise®” philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.The B.Braun group of companies includes B.Braun, Aesculap® and CAPS®. B.Braun’s U.S. headquarters is located in Bethlehem, Pennsylvania, with its global headquarters based in Melsungen, Germany. It employs more than 44,000 employees in more than 50 countries throughout the world.

Bedford, Massachusetts, Us

Recruited by VP Sales and Marketing to design and direct the implementation of the launch plans of a newly acquired, first in class injectable contrast agent for use in Magnet Resonance Angiography (MRA) for projected launch in less than 6 months. Created a new, US strategic brand plan based on the reality of a crowded contrast market, institutional barriers, and a product with a narrow indication. US launch: January 2010Directed the hire and training of 20 person contract field organization and 10 person medical liaison team, established a distribution/wholesaler channel for customer access, ensured reimbursement coverage, and developed sales collateral for the field to address multiple, key stakeholders. Created a business plan for the worldwide launch as well as a life cycle management plan for sustained growth over the next several years. Launched the brand in Canada, October 2010.

Bethlehem, Pa, Us

Managed $200M+ IV Drug Delivery, Fluid Therapy, and Pharm Admixture business containing over 150 individual products focused on the safe and efficient delivery of IV therapeutics. Created and implemented downstream marketing programs to drive sales through a direct sales force primarily focused on both hospital and outpatient markets. Received Marketing Excellence award.Drove overall profitability of complex product line including the development and implementation of pricing programs designed to drive incremental, profitable sales, pricing plan and negotiation strategy for GPO and IDN contracting, and maintained relationships with top distributors accounting for 90% of sales. Led a global marketing team providing strategic direction and customer acceptance criteria to a multi-billion dollar project to design and manufacture a new medical device for IV fluids delivery.Successfully launched 2 IV antibiotics in a propriety container at pricing 30 to 50% higher than like competition resulting in the turnaround of a business segment that had experienced negative, year on year earnings to a positive, double digit growth branded portfolio.

Franklin Lakes, New Jersey, Us

Joined Pharm Systems Division to establish new initiative focused on the development of new, innovative drug delivery systems including micro-needles, patches, and other injectable devices. Led planning for advanced medical device projects focused in multiple disease areas including Cancer Therapeutics, Rheumatoid Arthritis, Multiple Sclerosis, and FertilityAdvanced revenue producing opportunities with several pharmaceutical and bio-tech companies including Pfizer, Merck, Regeneron, and AstraZeneca.

Held several positions of increasing responsibility over a 21 year career at Du PontVice President, Strategic Planning and ROI Analysis (2001)Directed the strategic planning process as well as the development of financial performance metrics for Cardiovascular and Imaging Franchise (CVI).• Fostered strategic relationships with industry thought leaders, academia and professional societies resulting in integrated clinical and commercial plans including phase IV studies.• Led team in evaluation of sales force effectiveness, profit and/or loss of strategic initiatives, and market development opportunities resulting in optimized sales force deployment and resource allocation.Vice President, Cardiovascular and Thrombosis Marketing (1999-2000)Led 22 person Cardiovascular and Thrombosis Franchise Marketing function, which generated in excess of $1B in sales.• Established overall strategic and tactical direction for cardiovascular franchise brands.• Developed integrated therapeutic/imaging initiative resulting in more effective resource utilization.• Managed strategic partnerships with both Merck, generating over $1B in sales for Prinivil®/Prinzide®; and LEO Pharmaceuticals, providing US presence for launch of Innohep.Sr. Director, Medical Imaging Brand Management, Billerica, MA (1998-1999)Managed team of eight in strategic development and tactical direction for Medical Imaging Franchise in the following therapeutic categories: Cardiovascular, Oncology, and Neurology.• Designed, planned, and initiated Phase IV clinical trials focused on long-term growth strategies, specifically in Women’s Health, Diabetes, Congested Heart Failure, and PostMI resulting in record sales and profits.• Led Global Branding Team responsible for creating a worldwide brand image providing incremental sales while reducing costs. Global efforts also resulted in thought leader relationships that established DuPont as a worldwide leader in cardiac disease detection.